MJFF supports Oncodesign Precision Medicine's drug development program, while the EMA supports its toxicology strategy.

The entities involved

• foundation →

  type of nonprofit organization

  • Foundation uses US dollars for development projects.02:54
  • Life Time Foundation has been identified as Life Time's public nonprofit organization.00:23
• FDA →
  • Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.17:08
  • CVS Health's Caremark profit depends on drug payment gaps, while GRAIL awaits FDA approval until 2027, and Jim Cramer called CVS Health cheap.15:50

Related events

• IGC Pharma, Inc. is preparing data for potential U.S. FDA review and seeking EMA support for its lead drug candidate.Aug 11
• A company submitted study data supporting a PMA submission to the FDA.Jun 8
• A company plans to submit regulatory applications to the FDA, EMA, and Australian TGA.Sep 24
• Takeda announced FDA approval of its drug MIMRYLO, a decision supported by VERIFY results.Aug 29
• EMA validated marketing authorization and FDA accepted NDA for Pharvaris N.V.'s lead drug.Aug 25